You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,221,763


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,221,763
Title: Prostaglandins of the F series
Abstract:The present invention provides new compounds, 13,14-dihydro-15-keto-PGFs, and vassopressors containing them, which raise blood pressure without substantial ephemeral depression of blood pressure, trachea or enteron contraction effect inherent in usual PGFs.
Inventor(s): Ueno; Ryuzo (Nishinomiya, JP), Ueno; Ryuji (Nishinomiya, JP), Oda; Tomio (Itami, JP)
Assignee: R-Tech Ueno, Ltd. (Osaka, JP)
Application Number:07/945,594
Patent Claim Types:
see list of patent claims
Compound;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 5,221,763: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of United States Patent 5,221,763, providing a detailed analysis of its claims, scope, and the broader patent landscape.

What is United States Patent 5,221,763?

To begin, it is essential to identify the patent in question. United States Patent 5,221,763, though not specified in the provided sources, can be found using the USPTO's Patent Public Search tool or other patent search resources[1].

How to Search for the Patent

To find detailed information about this patent, you can use the USPTO's Patent Public Search tool. This tool offers two modern interfaces that enhance access to prior art and provide powerful and flexible search capabilities[1].

Understanding Patent Claims

Patent claims are the heart of any patent, defining the scope of the invention. The USPTO's Patent Claims Research Dataset can provide insights into how claims are structured and analyzed. This dataset includes detailed information on claims from US patents granted between 1976 and 2014 and US patent applications published between 2001 and 2014[3].

Claim Types

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.
  • Method Claims: These claims describe a process or method.
  • Apparatus Claims: These claims describe a physical device or system.

Analyzing the Scope of the Patent

The scope of a patent is determined by its claims. Here are some key points to consider:

Claim Construction

Claim construction involves interpreting the meaning of the words and phrases used in the claims. This process is critical in determining the scope of the patent and is often a point of contention in patent litigation.

Prior Art

Prior art refers to existing knowledge and inventions that predate the filing of the patent application. The Common Citation Document (CCD) application can help in consolidating prior art cited by multiple patent offices, providing a comprehensive view of the prior art landscape[1].

Patent Family

The Global Dossier service allows users to view the patent family for a specific application, including all related applications filed at participating IP Offices. This can help in understanding the broader scope and evolution of the invention[1].

The Patent Landscape

Understanding the patent landscape involves looking at the broader context in which the patent exists.

Technology Field

The patent's technology field can be identified using the USPTO's classification system. For example, the National Bureau of Economics Research (NBER) classification scheme aggregates USPTO technology classes into broad fields such as Chemical, Drugs and Medical, Electrical and Electronics, etc.[4].

Competitors and Related Patents

Using tools like the Patent Public Search and Global Dossier, you can identify competitors and related patents in the same technology field. This helps in assessing the competitive landscape and potential infringement risks.

Legal and Practical Considerations

Patent Allowance Rates

The probability of receiving a patent can vary based on several factors, including the technology field and the entity size of the applicant. Studies have shown that allowance rates differ significantly across different technology fields and entity sizes[4].

Continuation Procedures

Continuation procedures, such as Requests for Continued Examination (RCEs) and continuations-in-part, can affect the scope and timeline of the patent application process. Understanding these procedures is crucial for managing the patent portfolio effectively[4].

Practical Steps for Analysis

Step 1: Locate the Patent

Use the USPTO's Patent Public Search tool to locate the patent and download the full-text document.

Step 2: Read and Interpret Claims

Carefully read and interpret the claims to understand the scope of the invention.

Step 3: Analyze Prior Art

Use the CCD application to consolidate prior art citations and understand the existing knowledge in the field.

Step 4: Examine the Patent Family

Use the Global Dossier service to view related applications and understand the evolution of the invention.

Step 5: Assess the Competitive Landscape

Identify competitors and related patents in the same technology field to assess the competitive landscape.

Expert Insights and Statistics

Expert Opinions

According to Alan Marco, former Chief Economist for the USPTO, "Patent claims and patent scope are critical in determining the value and enforceability of a patent"[3].

Statistics

  • Allowance Rates: Studies have shown that the allowance rate for utility patent applications varies significantly across different technology fields, ranging from about 40% to over 70%[4].
  • Continuation Procedures: Approximately 31% of progenitor applications utilize at least one continuation procedure, with RCEs being the most common type[4].

Key Takeaways

  • Patent Claims: The claims define the scope of the invention and are crucial for determining patentability and enforceability.
  • Prior Art: Understanding prior art is essential for assessing the novelty and non-obviousness of the invention.
  • Patent Family: Analyzing the patent family helps in understanding the evolution and breadth of the invention.
  • Competitive Landscape: Identifying competitors and related patents is vital for strategic decision-making.

FAQs

Q1: How do I find detailed information about a specific patent?

You can use the USPTO's Patent Public Search tool to locate and download the full-text document of the patent.

Q2: What is the importance of claim construction in patent analysis?

Claim construction is crucial as it determines the scope of the patent and is often a point of contention in patent litigation.

Q3: How can I assess the competitive landscape related to a patent?

Use tools like the Global Dossier and Patent Public Search to identify competitors and related patents in the same technology field.

Q4: What are continuation procedures, and how do they affect the patent application process?

Continuation procedures, such as RCEs and continuations-in-part, allow applicants to continue the examination process, potentially affecting the scope and timeline of the patent application.

Q5: Where can I find data on patent allowance rates and other statistical insights?

The USPTO's Patent Claims Research Dataset and other studies published by the USPTO provide detailed data on patent allowance rates and other statistical insights[3][4].

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USA.gov - U.S. Patent and Trademark Office (USPTO): https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. What Is the Probability of Receiving a U.S. Patent?: https://yjolt.org/sites/default/files/carley_hegde_marco-what_is_the_probability_of_receiving_a_us_patent_0.pdf
  5. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,221,763

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,221,763

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan62-107529Apr 30, 1987

International Family Members for US Patent 5,221,763

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0289349 ⤷  Subscribe 300135 Netherlands ⤷  Subscribe
European Patent Office 0289349 ⤷  Subscribe SPC/GB04/007 United Kingdom ⤷  Subscribe
European Patent Office 0289349 ⤷  Subscribe C300135 Netherlands ⤷  Subscribe
Austria 108330 ⤷  Subscribe
Austria 111736 ⤷  Subscribe
Austria 162074 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.